Comparative Effectiveness and Safety of Oral Anticoagulants across Kidney Function in Patients with Atrial Fibrillation

BACKGROUND: Patients with atrial fibrillation (AF) and severely decreased kidney function were excluded from the pivotal NOAC trials, thereby raising questions about comparative safety and effectiveness in patients with reduced kidney function. The study aimed to compare oral anticoagulants across t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Circ Cardiovasc Qual Outcomes
Päätekijät: Yao, Xiaoxi, Inselman, Jonathan W., Ross, Joseph S., Izem, Rima, Graham, David J., Martin, David B., Thompson, Aliza M., Southworth, Mary Ross, Siontis, Konstantinos C., Ngufor, Che G., Nath, Karl A., Desai, Nihar R., Nallamothu, Brahmajee K., Saran, Rajiv, Shah, Nilay D., Noseworthy, Peter A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7580213/
https://ncbi.nlm.nih.gov/pubmed/33012172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.120.006515
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia